Navigation Links
Neurocrine Biosciences Reports Third Quarter 2008 Results
Date:10/28/2008

SAN DIEGO, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended September 30, 2008. For the third quarter of 2008, the Company reported a net loss of $17.7 million, or $(0.46) per share compared with a net loss of $27.2 million, or $(0.72) per share, for the same period in 2007. For the nine months, the Company reported a net loss of $59.8 million, or $(1.56) per share, as compared to $79.3 million, or $(2.09) per share, for the same period last year.

Revenues for the third quarter of 2008 were $0.8 million compared with $0.5 million for the same period last year. Revenues for the nine months ended September 30, 2008 were $3.2 million, compared with $0.7 million for the same period in 2007. The increase in revenues is primarily due to revenues recognized in 2008 under collaboration agreements with GlaxoSmithKline (GSK) and Dainippon Sumitomo Pharma Co., Ltd.

Research and development expenses decreased to $13.0 million during the third quarter of 2008 compared with $19.8 million for the same period in 2007. For the nine months ended September 30, 2008, research and development expenses were $43.4 million, compared to $57.6 million for the same period last year. The decrease in research and development expenses is primarily due to cost savings related to our restructuring in the fourth quarter of 2007.

General and administrative expenses were $3.5 million for the third quarter of 2008 and $9.6 million during the same period last year. For the nine months ended September 30, 2008, general and administrative expenses were $16.4 million, compared to $26.7 million for the first nine months of 2007. The reduction in general and admin
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
2. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
5. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
6. Neurocrine Biosciences Reports Second Quarter 2008 Results
7. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
8. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 2013 Oven Industries, Inc. has been ... and temperature sensors since 1964. Expertly designed, the ... control system applications. As one of the ... generic, control loop feedback system, which helps minimize errors. ... adjust a systematic process, using a control element, like ...
(Date:5/16/2013)... May 16, 2013 Cambridge Healthtech Institute ... August 19-23, 2013 at the Renaissance Waterfront Hotel in ... provide a close-up look at the current strategies and ... bottom-line quality. Leaders in the field will reveal ... produce biopharmaceuticals with greater specificity and efficiency. , “In ...
(Date:5/16/2013)... May 16, 2013  The registration deadline has been ... Officers (ABFO) 2013 National Conference, the premier conference for ... 28-31 at the Hilton San Diego Bayfront. ... year,s conference and want to make sure as many ... Brandi Roberts , Chief Financial Officer ...
(Date:5/16/2013)... 2013 On average, developing a new ... billion dollars. Despite this investment, less than 10% of ... is your clinical trial design optimally structured to balance ... , Dr. Frederic Sax, Global Head of the Center ... of data, information and technology in upfront clinical trial ...
Breaking Biology Technology:New PID Temperature Controllers Announced by Oven Industries Inc. 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... future, every manufactured product our clothes, money, appliances, ... floors, our cars will be embedded with intelligence, ... termed smart dust or an Internet of Things. The ... We already have surveillance systems, biometrics, personal communicators, machine ...
... Feb. 1 MannKind Corporation,(Nasdaq: MNKD ), focused ... announced today that it will present at,the Merrill Lynch ... 2008 at 1:40 PM ET at the Grand Hyatt ... a link to the live web cast of the,presentation ...
... CORONA, Calif., Feb. 1 Watson,Pharmaceuticals, Inc. (NYSE: ... today that Paul Bisaro, Watson,s president and chief,executive ... the Company,s,business at the 2008 Merrill Lynch Global ... 5, 2008 at 1:40 p.m. Eastern,Standard Time., ...
Cached Biology Technology:Supportive devices or unnecessary surveillance? 2
(Date:5/16/2013)... entirety of an individual,s DNA is examined to look ... health problems is a massively useful technology for diagnosing ... problems if used incorrectly, say new recommendations from the ... today (16 May 2013) in the European Journal ... genome and on exome* sequencing and analysis are now ...
(Date:5/16/2013)... 2013 The consultancy Frost & ... to Germany,s largest biometrics manufacturer, ... system. DERMALOG has been honored yesterday night ... in the category Global Biometrics and Border Control  Customer ...   Border Control System . One of the decisive ...
(Date:5/15/2013)... - Clam fossils from the middle Devonian era ... better paleontological picture of the capacity of ecosystems to ... to research published today (May 15) in the online ... species abundance the head counts of specimens ... research shows that factors such as predation and organism ...
Breaking Biology News(10 mins):European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Clam fossils divulge secrets of ecologic stability 2
... implicates the primary chemical used to produce hard plasticsbisphenol ... its consequences. In a laboratory study, using fresh ... suppresses a key hormone, adiponectin, which is responsible for ... at a substantially higher risk for metabolic syndrome. ...
... SPRING HARBOR, N.Y. (Sept. 4, 2008) A ... animalshave biological rhythms, where the timing and duration of ... to adapt and survive, even under fluctuating environmental conditions. ... to understand the molecular basis of these rhythms and ...
... cell research is the next great leap in medicine. In ... a failing heart, or new cells take the place of ... from embryonic sources, which opens difficult ethical and complicated scientific ... culled from a person,s own body. Adult stem cells are ...
Cached Biology News:Bisphenol A linked to metabolic syndrome in human tissue 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2Tel Aviv University researchers create new stem cell screening tool 2
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI RAT RT1Bu Immunogen: Rat thymocyte membrane glycoproteins...
... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...
SHEEP ANTI HUMAN ESTRONE...
Biology Products: